The largest database of trusted experimental protocols

Infinitum 660 w quad

Manufactured by Illumina
Sourced in United States

The Infinitum 660 W-Quad is a high-throughput, next-generation DNA sequencing platform designed for large-scale genomic analysis. It features a quad-channel configuration that allows for parallel processing of multiple samples simultaneously, increasing overall throughput and efficiency.

Automatically generated - may contain errors

4 protocols using infinitum 660 w quad

1

Genome-wide association study data processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The discovery GWAS included genotyped as well as imputed SNPs for better coverage. Sample genotypes were phased and missing markers were imputed using the software IMPUTE2 (ref. 54 (link)). Phased data of 1,094 samples from the 1000 Genomes Project (www.1000genomes.org) were used as the reference data set. These samples are from African, African American, Asian, Caucasian and Native American populations. We excluded SNPs with an information coefficient value <0.5 and minor allele frequency <1%. For markers in the MEC data, we conducted additional stringent quality-control analyses to exclude SNPs with different minor allele frequencies in controls typed on or imputed from different genotyping platforms. SNPs that exhibited differences in minor allele frequencies between the controls genotyped with the Illumina Infinitum 660 W-Quad or Omni 2.5 M platforms at P<0.01, and/or had ORs >10 or <0.1 were excluded. The final GWAS analysis included 7,229,558 SNPs.
+ Open protocol
+ Expand
2

Affymetrix and Illumina genotyping for US Latina GWAS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SFBCS, NC-BCFR and GALA1 samples were genotyped with the Affymetrix 6.0 array according to the manufacturer’s instructions in the Laboratory of Esteban Gonzalez Burchard at UCSF. The MEC samples were genotyped with the Illumina Infinitum 660 W-Quad or the Omni 2.5 array in the Genomics Center at USC and at the Broad Institute (Cambridge, MA, USA).
Before imputation, we excluded 15 cases and 30 controls from the SFBCS/NC-BCFR/GALA1 set that had a genotyping call rate <95% or showed either known or cryptic relatedness. We excluded 26 cases and 8 controls from the MEC because of unexpected relatedness. The final analysis included 1,497 cases and 3,213 controls (1,699 individuals from the SFBCS/NC-BCFR/GALA1 set (977 cases and 722 controls) and 3,011 from the MEC (520 cases and 2,491 controls)).
A scatter plot of the first and second principal components estimated for the US Latina samples included in the discovery phase of the study showed the expected distribution for this population, with most samples spreading between the European and Asian axes (and beyond the Asian cluster towards what would be the Indigenous American cluster) and a smaller proportion of samples deviating towards the African cluster (Supplementary Fig. 5).
+ Open protocol
+ Expand
3

Optimized GWAS Imputation and QC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The discovery GWAS included genotyped as well as imputed SNPs for better coverage. Sample genotypes were phased and missing markers were imputed using the software IMPUTE254 (link). Phased data of 1094 samples from the 1000 Genomes Project (www.1000genomes.org) were used as the reference dataset. These samples are from African, African American, Asian, Caucasian, and Native American populations. We excluded SNPs with an information coefficient value <0.5 and minor allele frequency <1%. For markers in the MEC data, we conducted additional stringent quality control analyses to exclude SNPs with different minor allele frequencies in controls typed on or imputed from different genotyping platforms. SNPs that exhibited differences in minor allele frequencies between the controls genotyped with the Illumina Infinitum 660W-Quad or Omni 2.5M platforms at p <0.01, and/or had ORs >10 or <0.1 were excluded. The final GWAS analysis included 7,229,558 SNPs.
+ Open protocol
+ Expand
4

Genotyping and Quality Control of Latina Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SFBCS, NC-BCFR and GALA1 samples were genotyped with the Affymetrix 6.0 array according to the manufacturer's instructions in the laboratory of Esteban Gonzalez Burchard at UCSF. The MEC samples were genotyped with the Illumina Infinitum 660W-Quad or the Omni 2.5 array in the Genomics Center at USC and at the Broad Institute (Cambridge, MA).
Before imputation, we excluded 15 cases and 30 controls from the SFBCS/NC-BCFR/GALA1 set that had a genotyping call rate <95% or showed either known or cryptic relatedness. We excluded 26 cases and 8 controls from the MEC due to unexpected relatedness. The final analysis included 1497 cases and 3213 controls [1,699 individuals from the SFBCS/NC-BCFR/GALA1 set (977 cases and 722 controls) and 3011 from the MEC (520 cases and 2491 controls)].
A scatter plot of the 1st and 2nd principal components estimated for the U.S. Latina samples included in the discovery phase of the study showed the expected distribution for this population, with most samples spreading between the European and Asian axis (and beyond the Asian cluster towards what would be the Indigenous American cluster) and a smaller proportion of samples deviating towards the African cluster (Supplementary Figure 5).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!